Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6947334

Cc1ccc(CN)cc1.N

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2A6 P11509 1/20 0.59
HRH3 Q9Y5N1 1/20 0.55
LOXL2 Q9Y4K0 5/20 0.52
AGXT P21549 2/20 0.50
IDO1 P14902 2/20 0.50
ABAT P80404 1/20 0.50
ACHE P22303 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PSIP1 O75475 1/20 0.44
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11699 0.97
SCHEMBL29277663 0.94
Iodide SCHEMBL31425559 0.94 TAAR1 (0.59) TAAR1CYP1A2CYP2A6HRH3LOXL2
Bromide SCHEMBL31513706 0.94 TAAR1 (0.59) TAAR1CYP1A2CYP2A6HRH3LOXL2
Hydrochloric Acid SCHEMBL1938665 0.94 TAAR1 (0.59) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL260102 0.89 HRH3 (0.74) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL28414434 0.87 TAAR1 (0.52) TAAR1CYP1A2CYP2A6HRH3LOXL2
SCHEMBL28196044 0.85 TAAR1 (0.50) TAAR1CYP1A2CYP2A6HRH3LOXL2
P-Xylene SCHEMBL27449807 0.83 LOXL2 (0.74) TAAR1CYP1A2CYP2A6LOXL2ACHE
SCHEMBL13929440 0.83 TAAR1 (0.48) TAAR1CYP1A2CYP2A6HRH3LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649627-B1 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea SANOFI-SYNTHELABO (FR) 2003-11-18 US disclosed
EP-1087961-B1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI SYNTHELABO (FR) 2002-08-14 EP disclosed
EP-1087961-A1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI-SYNTHELABO (FR) 2001-04-04 EP disclosed
WO-1999065895-A1 PHENOXYLPROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME SANOFI-SYNTHELABO (FR) 1999-12-23 WO disclosed
EP-0434213-B1 Monosubstituted dithiooxamide compounds and their use MINNESOTA MINING & MFG (US) 1995-04-05 EP disclosed
US-5124308-A Reacts with transition metal salt for carbonless paper copying MINNESOTA MINING AND MANUFACTURING COMPANY 1992-06-23 US disclosed
US-5041654-A Transamination in wallach reaction; controlling temperature; reactant amine concentration MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-08-20 US disclosed
EP-0434213-A1 Monosubstituted dithiooxamide compounds and their use MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-06-26 EP disclosed
EP-0431783-A1 Preparation of monosubstituted dithiooxamide compounds MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-06-12 EP disclosed